PAA 2.44% 21.0¢ pharmaust limited

Pharmaust Phase II K9 Trial, page-466

  1. 12,272 Posts.
    lightbulb Created with Sketch. 6278
    Generally would agree but companies just cant hold material information, it must be put to market...

    Plus Management will be walking into a Lions Den... we can certainly strike off any talk of Performance Pay or additional shares..... that would just be Vulgar Talk ,,,,, Effort means nothing,,,,, Results speaks Volumes..... Silence is Frustrating and suppressing awareness which hampers information to market and that certainly doesn't attract new shareholders ....
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.